CS
DAWN

Credit Suisse’s Day One Biopharmaceuticals DAWN Stock Holding History

Credit Suisse’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$779K Hold
47,149
– – ﹤0.01% 2409
2023
Q4 		$688K Buy
47,149
+5,200
+12% +$63K ﹤0.01% 2568
2023
Q3 		$515K Sell
41,949
-15,453
-27% -$202K ﹤0.01% 2674
2023
Q2 		$685K Buy
+57,402
New +$750K ﹤0.01% 2625
2023
Q1 		– Sell
-1
Closed -$22 – 3376
2022
Q4 		$22 Sell
1
-156
-99% -$3.2K ﹤0.01% 3660
2022
Q3 		$3K Buy
157
+134
+583% +$2.85K ﹤0.01% 3668
2022
Q2 		$0 Buy
+23
New +$238 ﹤0.01% 4003

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse's DAWN Position: Q1 2024 in Review

Credit Suisse held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2024 at 47,149 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Credit Suisse first reported a position in DAWN in Q2 2022 and has held it in 7 quarters since. 149 funds tracked by Wall St. Rank hold DAWN as of Q1 2024.

  • Credit Suisse held 47,149 shares of Day One Biopharmaceuticals worth $779K as of Q1 2024.
  • Credit Suisse left its Day One Biopharmaceuticals share count unchanged in Q1 2024.
  • Day One Biopharmaceuticals made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2409 holding.
  • Credit Suisse first reported a position in Day One Biopharmaceuticals in Q2 2022 and has held it in 7 quarters since.
  • 149 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.